Advertisement

Topics

Achillion Pharmaceuticals, Inc. (ACHN) Receives Consensus Rating of "Buy" from Brokerages

02:44 EDT 21 Jun 2017 | Topix

Shares of Achillion Pharmaceuticals, Inc. have earned an average rating of "Buy" from the eleven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company.

Original Article: Achillion Pharmaceuticals, Inc. (ACHN) Receives Consensus Rating of "Buy" from Brokerages

NEXT ARTICLE

More From BioPortfolio on "Achillion Pharmaceuticals, Inc. (ACHN) Receives Consensus Rating of "Buy" from Brokerages"

Advertisement
Quick Search
Advertisement
Advertisement